O’Ryan Health

What O’Ryan Health does

O'Ryan Health is a privately-held pediatric health technology company headquartered at 33 Kirkland Circle, Wellesley, Massachusetts, that provides at-home capillary blood collection and laboratory testing services for children and families in the United States. The company operates the Artemis Platform, an end-to-end logistics and informatics system that manages virtual enrollment, guided collection via the validated RedDrop ONE capillary device, and compliant sample transport to CLIA-certified laboratory partners including Aura Genetics (CLIA-certified, CAP-accredited, Louisville, Kentucky), Celesta Health, and Meridian Valley Lab. Results are delivered through a secure Parent Portal that can be shared with a child's healthcare team, and the company explicitly excludes the European Union from its geographic footprint.

The company runs three concurrent go-to-market motions: a direct-to-parent product-led channel through the Parent Portal and Superhero Shop selling allergy (IgE), food sensitivity (IgG4), and routine wellness kits on minimum 6-month subscriptions (HSA/FSA eligible as of May 2026); an enterprise field sales channel targeting state Medicaid programs and Rural Health Transformation Programs via a fixed-cost standardized kit model; and a community-led motion leveraging IRB-approved pediatric research studies spanning medulloblastoma, autism spectrum disorder, juvenile dermatomyositis, and healthy kids cohorts. Revenue streams therefore include recurring DTC subscriptions, multi-year government program contracts, and managed-services partnerships with healthcare organizations supporting value-based care models.

Recent strategic activity is dense: partnerships with Aura Genetics (March 2026), Celesta Health (February 2026), Molecule Science Foundation (twice in May 2026), and BlueSavant AI (May 2026), plus the national launch of direct-to-parent testing (February 2026) and HSA/FSA approval (May 2026). The company is led by co-founder Tim Coleman (Architect of Operations). No revenue figures, funding rounds, or headcount have been disclosed in the available data, and the company does not report a public listing.

Name

O’Ryan Health

Legal name

O'Ryan Health Inc.

Website

https://oryan.health

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

O'Ryan Health is a pediatric health technology company providing at-home capillary blood collection and laboratory testing for children via its Artemis Platform and RedDrop ONE device. It serves families through direct-to-parent wellness kits, Medicaid and RHTP government programs, healthcare organization partnerships, and pediatric research studies.

Ownership category

akta.pro rank

Product category

Pediatric At-Home Diagnostic Testing

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Home Health Care Services (8082), Services-Medical Laboratories (8071)

akta.pro primary industry

Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)

akta.pro secondary industry

Pediatrics & Adolescent Medicine Practices (HLAFAJAF)

Keywords

• Pediatric blood testing
• At-home diagnostics
• Capillary blood collection
• Allergy testing services
• Food sensitivity panels

Headquarters

HQ city

Wellesley

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Direct-to-Parent Wellness Kit Sales: Parents purchase wellness kits for food sensitivities, airborne allergens, and routine blood testing through the Superhero Shop in the Parent Portal. Now HSA/FSA eligible, removing cost barriers for families. Subscription model with minimum 6-month terms, payable monthly or annually.
2. Medicaid and Government Program Contracts: Partnerships with states implementing Rural Health Transformation Programs (RHTP) to deliver at-home pediatric diagnostic access for rural and underserved communities under Medicaid. Fixed-cost standardized diagnostic kit model with predictable, auditable expenses scaling with program participation.
3. Healthcare Organization Partnerships: Partnerships with healthcare organizations and value-based care programs providing home-based diagnostic access. Laboratory testing performed by partners (Celesta Health, Aura Genetics, Meridian Valley Lab) with results delivered through O'Ryan Health's platform.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

O'Ryan Health enables parents to collect small capillary blood samples from children at home using the RedDrop ONE device, then ships those samples via its Artemis logistics platform to CLIA-certified laboratory partners (Meridian Valley Lab, Celesta Health, Aura Genetics) for allergy, food sensitivity, and routine pediatric wellness testing. Results are returned to families through a secure Parent Portal and can be shared with the child's healthcare team. The company also provides at-home pediatric diagnostic infrastructure to state Medicaid Rural Health Transformation Programs and conducts IRB-approved pediatric research studies.

Product overview

O'Ryan Health is a pediatric-focused health technology company providing at-home blood collection and laboratory access for children through its Artemis Platform and Parent Portal. The core offering consists of the RedDrop ONE capillary blood collection device paired with laboratory testing services (via partners Meridian Valley Lab, Celesta Health, and Aura Genetics) for allergy, food sensitivity, and wellness testing. The company operates a direct-to-consumer model where parents order testing kits, collect blood samples at home, and receive results through the Parent Portal which can be shared with healthcare providers. O'Ryan Health also conducts multiple pediatric research studies (medulloblastoma, autism, JDM, healthy kids) using the same at-home collection infrastructure. Recent expansions include HSA/FSA eligibility for wellness kits, partnerships for rural health programs, and research collaborations for autism and JDM using AI analysis.

Differentiator

Problem solved

Functional benefit

Brands

• Artemis Platform: Logistics and informatics platform for pediatric diagnostic access, managing enrollment, kit logistics, sample transport, and result delivery.
• RedDrop ONE
• FoodSafe IgG4
• Inhalant Allergen IgE Profile

Products and services

• Artemis Platform End-to-end logistics and informatics platform managing virtual enrollment, guided blood sample collection, compliant sample transport to CLIA-certified laboratories, and result delivery; integrates with UPS logistics and is offered to Medicaid programs and healthcare organizations as infrastructure for home-based pediatric diagnostics.
• RedDrop ONE Device Capillary blood collection device that sticks to a child's arm or leg and provides a quick, nearly painless pinch to collect small blood samples, enabling safe parent-administered at-home blood collection validated across 19 U.S. states.
• Parent Portal Secure digital platform where families register, order wellness and allergy test kits through the Superhero Shop, access test results, manage their family's testing history, and download/share results with healthcare teams; HSA/FSA eligible purchasing available.
• Inhalant Allergen IgE Profile Laboratory test panel assessing reactions to 27 common airborne allergens including pollen, mold, and animal dander; results reported quantitatively in kU/L with population-based percentile interpretation.
• FoodSafe IgG4 95 Pediatric Allergan Test Kit Laboratory test evaluating delayed immune responses (IgG4) to 94 common foods plus Candida to detect food sensitivities associated with fatigue, headaches, digestive discomfort, and skin irritation.
• FoodSafe IgG4 190 Combo Pediatric Allergan Test Kit Expanded food sensitivity testing across 189 foods plus Candida, covering grains, dairy, meats, seafood, fruits, vegetables, herbs, spices, nuts, and additives; semi-quantitative reporting categorized as Low, Moderate, or High.
• Wellness Kit Subscriptions Subscription-based wellness kits offered to parents covering food sensitivity, airborne allergen, and routine blood testing; minimum 6-month subscription terms, payable monthly or 100% annually; HSA/FSA eligible.

Quantifiable outcome

• High first-attempt success rates with low reported pain and short collection times
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature3 records

Partnerships

Seven partnerships are on record, tiered flagship and core.

• Molecule Science FoundationflagshipStrategic or Co-development Partner · 26 May 2026Research partnership to build the largest decentralized bulk RNA dataset for Autism Spectrum Disorder (ASD). Molecule Science Foundation provides legal and technical infrastructure mobilizing a community of contributors around a coordinated charitable fundraise. O'Ryan Health's Artemis Platform enables decentralized collection of pediatric blood samples at scale. The study will enroll children with confirmed ASD diagnosis and neurotypical children as comparison cohort, generating approximately 200 RNA expression profiles.
• BlueSavant AIflagshipStrategic or Co-development Partner · 26 May 2026Partnership with O'Ryan Health and Molecule Science Foundation to advance autism research. BlueSavant AI's proprietary models analyze bulk RNA expression data to identify biological patterns associated with ASD. Collaboration combines high-quality, real-world RNA collected directly from families at home with BlueSavant AI's Autism AI model trained on large transcriptomic datasets.
• Molecule Science FoundationflagshipStrategic or Co-development Partner · 19 May 2026Research partnership to build the largest decentralized single-cell immune dataset for Juvenile Dermatomyositis (JDM), a rare and serious pediatric autoimmune condition. Families collect small-volume blood samples at home using RedDrop ONE device; samples are transformed into single-cell RNA sequence data called 'Immune Avatars' serving as digital models of a child's immune system. IRB-approved study creates contiguous understanding of pathogenic immune signals driving JDM.
• Aura GeneticscoreStrategic or Co-development Partner · 3 March 2026Strategic partnership to deliver at-home pediatric capillary blood testing for Rural Health Transformation Programs. O'Ryan Health provides the Artemis Platform logistics infrastructure; Aura Genetics processes samples at its new CLIA-certified automated testing facility in Louisville, Kentucky with capacity to process tens of thousands of samples per day. Partnership supports states implementing RHTP by delivering convenient, secure at-home blood testing for children in rural and underserved communities.
• Meridian Valley LabcoreTechnology or Integration · 27 February 2026CLIA-certified clinical laboratory (operating since 1976) performs allergy and food sensitivity testing for O'Ryan Health's direct-to-parent testing program. Provides FoodSafe IgG4 panels (94 and 189 foods + Candida) and Inhalant Allergen IgE Profile assessing 27 common airborne allergens with quantitative reporting.
• Celesta HealthcoreStrategic or Co-development Partner · 12 February 2026Partnership to make routine pediatric wellness blood testing available in the home. Celesta Health performs laboratory testing; O'Ryan Health provides at-home collection infrastructure using RedDrop ONE device. Results delivered to O'Ryan Health Parent Portal, enabling families to securely access and share information with their child's care team.
• RedDrop DxcoreTechnology or IntegrationManufacturer of the RedDrop ONE capillary blood collection device used for parent-administered at-home pediatric blood collection. Funded the IRB-approved validation study that demonstrated families can safely and reliably collect clinically meaningful blood samples at home. O'Ryan Health served as independent evaluator.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Function Health: Membership-based D2C lab testing platform offering comprehensive bloodwork and longitudinal tracking. Comparable consumer-facing subscription model for proactive lab testing, though adult-focused with national phlebotomy network rather than home collection.
• Babson Diagnostics: Retail-based capillary blood testing with miniaturized diagnostic instruments. Emerging peer in convenient, low-volume capillary sampling, with overlapping vision of decentralized diagnostics though delivered via retail rather than home.

Broad incumbents

• Quest Diagnostics: Large incumbent clinical laboratory offering mobile/at-home phlebotomy services (Quest Mobile) and direct-to-consumer testing through partners. Comparable in lab testing fulfillment and Medicaid contracting, but operates at vastly larger scale and not pediatric-specialized.
• Labcorp: Major clinical laboratory with at-home collection services (Labcorp At Home) and extensive pediatric test menu. Comparable in CLIA-certified pediatric lab testing and Medicaid contracting at scale; broad incumbent rather than niche pediatric specialist.

Direct peers

• Drawbridge Health: Maker of the OneDraw at-home capillary blood collection device. Comparable in offering a single-use, patient-friendly blood collection device for decentralized lab testing; directly overlaps with RedDrop ONE's value proposition.
• Tasso: Developer of the Tasso OnDemand at-home capillary blood collection device. Closest direct peer in pediatric/family-friendly at-home blood collection hardware and decentralized research; comparable model of enabling remote sample collection for clinical and research use.
• Seventh Sense Biosystems: Developer of the TAP (Touch Activated Phlebotomy) device for virtually painless capillary blood collection. Comparable in single-use, patient-friendly blood collection technology targeting decentralized testing and research applications.
• LetsGetChecked: D2C at-home lab testing company with subscription-based wellness panels and integrated logistics. Comparable GTM motion of direct-to-consumer ordering, kit shipping, CLIA-lab processing, and digital results delivery.
• Yourbio Health: Maker of the TAP II at-home capillary blood collection device used in clinical trials and remote research. Comparable in enabling decentralized clinical research through patient-administered blood collection kits shipped direct-to-home.
• Everlywell: Direct-to-consumer at-home lab testing platform with broad panels and parent-facing ordering model. Closest D2C at-home testing peer in business model and consumer funnel, though adult-focused rather than pediatric-specialized.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/o-ryan-therapeutics-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about O’Ryan Health